glp 1 agonist new GLP-1 and Anesthesia: Considerations and Cautions for CRNAs New GLP-1 Guidelines for Type

These conditions may rule out tirzepatide entirely, making alternatives not just preferable but medically necessary

However, the potential for delaying or preventing the progression of T2DM in patients treated with GIP and GLP-1 remains uncertain, as there is currently no definitive evidence from human studies demonstrating that enhanced incretin activity directly affects -cell mass or alters the progressive loss of insulin secretory capacity in humans

Stay well-hydrated , particularly if you experience gastrointestinal side effects

The most common side effects of these drugs are mild gastrointestinal (GI) issues